OCULAR THERAPEUTIX, INC Repayments of Long-Term Debt
OCULAR THERAPEUTIX, INC (OCUL) reported Repayments of Long-Term Debt of $26.13 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-02-05
- OCULAR THERAPEUTIX, INC repayments of long-term debt for the quarter ending 2023-12-31 was $0.00.
- OCULAR THERAPEUTIX, INC repayments of long-term debt for fiscal 2023 was $26.13M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $26.13M 10-K · filed 2026-02-05 | |
| 2023-09-30 | $26.13M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |